About: http://hub.abes.fr/oup/periodical/jac/1981/volume_8/issue_supplb/w

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : http://hub.abes.fr/oup/periodical/jac/1981/volume_8/issue_supplb/w Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/oup/periodical/jac/1981/volume_8
has manifestation of work	http://hub.abes.fr/oup/periodical/jac/1981/volume_8/issue_supplb/m/print http://hub.abes.fr/oup/periodical/jac/1981/volume_8/issue_supplb/m/web
Date Copyrighted	1981
Rights	© 1981 The British Society for Antimicrobial Chemotherapy
issue	suppl_B
is Is Part Of of	Pre-clinical safety evaluation of ceftazidime Penetration of ceftazidime into extracellular fluid in patients An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokinetic The pharmacy of ceftazidime The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers Antibacterial activity of ceftazidime (GR 20263) against routine hospital isolates and highly resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa In-vitro activity of ceftazidime, a β-lactamase stable cephalosporin Activity of ceftazidime against Pseudomonas aeruginosa from bacteraemic and fibrocystic patients Ceftazidime regression studies Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid Ceftazidime in Gram-negative infections: three case reports Ceftazidime: therapeutic results in various infections and kinetic studies An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests The microbiological assay of ceftazidime A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin The in-vivo antibacterial activity of ceftazidime (Gr 20263)—a comparison with other new β-lactam antibiotics and gentamicin Ceftazidime activity in experimental pseudomonas pyelonephritis in rats Human pharmacokinetics of ceftazidime in comparison to moxalactam and cefotaxime—abstract Ceftazidime: comparative in-vitro study Assay of ceftazidime in biological fluids using high-pressure liquid chromatography The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers Clinical experience in the treatment of lower respiratory tract infections with ceftazidime Pharmacokinetics and efficacy of ceftazidime in experimental Haemophilus influenzae b meningitis The in-vitro activity of ceftazidime compared with that of other cephalosporins Behaviour of ceftazidime towards β-lactamases Ceftazidime susceptibility testing—disc loading Clinical experience with ceftazidime for lower respiratory tract infections Ceftazidime: summary of the First International Symposium The penetration of ceftazidime into extravascular fluid Comparative in-vitro activity of ceftazidime (GR 20263) and other β-lactamase stable cephalosporins against pseudomonas In-vitro activity of ceftazidime compared with other β-lactam antibiotics The in-vitro activity of ceftazidime: comparison with other β-lactam antibiotics Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa Ceftazidime: in-vitro antibacterial activity and susceptibility to β-lactamases compared with that of cefotaxime, moxalactam and other β-lactam antibiotics Treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa—a comparison of the efficacy of ceftazidime with that of netilmicin Activity of ceftazidime against Gram-negative bacilli from paediatric patients The immunosuppressive effect of cephalosporins and cephalosporin-gentamicin combinations Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid In-vitro studies with ceftazidime against aerobic Gram-negative bacilli and Bacteroides fragilis group List Of Participants Influence of bacterial β-lactamase production on susceptibility in agar or broth to new cephalosporins Bacteriological investigations with ceftazidime in vitro The in-vitro activity of ceftazidime against clinically important pathogens In-vitro studies with ceftazidime Pharmacokinetics of ceftazidime in normal subjects Use of ceftazidime in severe Gram-negative infections — a preliminary study Index In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria The susceptibility of nosocomial pathogens to ceftazidime The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis The in-vitro properties of ceftazidime Why ceftazidime? Growth curves of Escherichia coli and Pseudomonas aeruginosa submitted to different ceftazidime concentrations Susceptibility of ceftazidime and other cephalosporins to a range of β-lactamases and their potential as inducing agents In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal β-lactamases Renal tolerance of ceftazidime in animals Evaluation of ceftazidime in the treatment of severe infection Activity of ceftazidime and newer antibiotics against Gram-negative bacilli Comparative in-vitro activity of ceftazidime (GR-20263) and other β-lactamase stable cephalosporins against anaerobic bacteria Preface Trial of ceftazidime efficacy in respiratory infections at two dose levels Clinical and bacteriological evaluation of ceftazidime (GR 20263) as an antipseudomonal drug

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata